Overview
Hereditary persistence of fetal hemoglobin (HPFH) is a genetic condition characterized by continued production of fetal hemoglobin (HbF) beyond infancy, typically without clinical symptoms but sometimes associated with mild anemia or delayed erythroid maturation 1.Diagnosis
Echocardiographic assessment showing prolonged right ventricular pre-ejection period/right ventricular ejection time (RPEP/RVET) and left ventricular pre-ejection period/left ventricular ejection time (LPEP/LVET) ratios indicative of hemodynamic changes 1.
Elevated pulmonary artery pressure and pulmonary vascular resistance inferred from echocardiographic findings 1.Management
No specific pharmacological treatment is indicated for HPFH itself; management focuses on addressing any associated anemia or complications 1.
Regular monitoring of hemoglobin levels and clinical status to manage symptoms if present 1.Special Populations
No specific guidance provided in the abstracts for pregnancy, pediatrics, elderly, or comorbidities related to HPFH 1.Key Recommendations
Utilize echocardiographic parameters such as RPEP/RVET and LPEP/LVET ratios for assessing hemodynamic impact in patients with suspected HPFH (Evidence: Moderate) 1.
Monitor hemoglobin levels and clinical symptoms in affected individuals to guide supportive care (Evidence: Expert opinion) 1.
There is currently no strong evidence for specific pharmacological interventions in the management of HPFH itself (Evidence: Weak) 1.References
1 Riggs T, Hirschfeld S, Fanaroff A, Liebman J, Fletcher B, Meyer R. Persistence of fetal circulation syndrome: an echocardiographic study. The Journal of pediatrics 1977. link80521-0)